Research programme: designed repeat proteins - Molecular Partners/Roche

Drug Profile

Research programme: designed repeat proteins - Molecular Partners/Roche

Latest Information Update: 16 Nov 2012

Price : $50

At a glance

  • Originator Molecular Partners AG
  • Developer Molecular Partners AG; Roche
  • Class Proteins
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Research Unspecified

Most Recent Events

  • 16 Nov 2012 Early research development is ongoing in Switzerland
  • 20 Oct 2010 Early research development is ongoing in Switzerland
  • 28 Feb 2007 Early research in Undefined indication in Switzerland (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top